Instrument details

Instrument Title

The CRAFFT Screening Self-Administered Interview

View PDF - CRAFFT Self-Administered Tool_ Knight.pdf

Source Article

Knight, J. R., Shrier, L. A., Bravender, T. D., Farrell, M., Vander Bilt, J., & Shaffer, H. J. (1999). A new brief screen for adolescent substance abuse. Archives of Pediatrics & Adolescent Medicine, 153(6), 591.

Response Options

YES or NO (Y or N)

Survey Items

Part A
During the PAST 12 MONTHS, did you:

  1. Drink any alcohol (more than a few sips)?
  2. Smoke any marijuana or hashish?
  3. Use anything else to get high? (“anything else” includes illegal drugs, synthetic marijuana, over-the-counter and prescription drugs, or things that people sniff or “huff”)

If you answered NO to ALL (A1, A2, A3) answer only B1 below, then STOP.
If you answered YES to ANY (A1, A2, A3), answer B1 to B6 below.

Part B
  1. Have you ever ridden in a CAR driven by someone (including yourself) who was “high” or had been using alcohol or drugs?
  2. Do you ever use alcohol or drugs to RELAX, feel better about yourself, or fit in?
  3. Do you ever use alcohol or drugs while you are by yourself, or ALONE?
  4. Do you ever FORGET things you did while using alcohol or drugs?
  5. Do your FAMILY or FRIENDS ever tell you that you should cut down on your drinking or drug use?
  6. Have you ever gotten into TROUBLE while you were using alcohol or drugs?

Internal Reliability

Cronbach's alpha =0.79

Validity

Validity information was not available.

Google Scholar

View article on Google Scholar

Terms Of Use

Individuals may use this information for research or educational purposes only and may not use this information for commercial purposes. When using this instrument, please cite:

Knight, J. R., Shrier, L. A., Bravender, T. D., Farrell, M., Vander Bilt, J., & Shaffer, H. J. (1999). A new brief screen for adolescent substance abuse. Archives of Pediatrics & Adolescent Medicine, 153(6), 591.

When presenting results using any survey information you obtained from the SABI, please acknowledge the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded program P30 AI50410.